Life-saving drugs are a business like anything else, which means the pharmaceutical industry is optimized for profits, not people. Investors, mergers, and regulators control whether or not your loved ones can receive the medicine they need, when they need it. What does it take to get this stuff to market?
In For Blood and Money, financial journalist Nathan Vardi explores the development of a groundbreaking cancer drug. It all began when a small team working at a California-based biotech startup discovered a compound with incredible cancer-fighting properties. As patients experienced remarkable recoveries, the team realized the magnitude of their discovery.
Then the investors swooped in.